These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
857 related articles for article (PubMed ID: 9615269)
1. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis. Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269 [TBL] [Abstract][Full Text] [Related]
2. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study. Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381 [TBL] [Abstract][Full Text] [Related]
3. Peptidergic nerves in the colon of patients with ulcerative colitis. Tomita R; Tanjoh K; Fujisaki S; Fukuzawa M Hepatogastroenterology; 2000; 47(32):400-4. PubMed ID: 10791200 [TBL] [Abstract][Full Text] [Related]
4. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer. Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515 [TBL] [Abstract][Full Text] [Related]
5. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Bernstein CN; Robert ME; Eysselein VE Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884 [TBL] [Abstract][Full Text] [Related]
7. Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis. Jönsson M; Norrgård O; Hansson M; Forsgren S Ann N Y Acad Sci; 2007 Jun; 1107():280-9. PubMed ID: 17804556 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Griga T; May B; Pfisterer O; Müller KM; Brasch F Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933 [TBL] [Abstract][Full Text] [Related]
9. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178 [TBL] [Abstract][Full Text] [Related]
10. Mucosal and plasma prostaglandin E2 in ulcerative colitis. Wiercinska-Drapalo A; Flisiak R; Prokopowicz D Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993 [TBL] [Abstract][Full Text] [Related]
11. High-magnification chromoscopic colonoscopy in ulcerative colitis: a valid tool for in vivo optical biopsy and assessment of disease extent. Hurlstone DP; Sanders DS; McAlindon ME; Thomson M; Cross SS Endoscopy; 2006 Dec; 38(12):1213-7. PubMed ID: 17163321 [TBL] [Abstract][Full Text] [Related]
12. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594 [TBL] [Abstract][Full Text] [Related]
13. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Griga T; Voigt E; Gretzer B; Brasch F; May B Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639 [TBL] [Abstract][Full Text] [Related]
14. Expression of the Kp43 (CD 94) receptor by natural killer (NK) cells in ulcerative colitis. del Mar Cabrera M; Valle J; Pajares JM; Romero I; Zomeño M; Maté J Hepatogastroenterology; 2001; 48(41):1316-20. PubMed ID: 11677954 [TBL] [Abstract][Full Text] [Related]